Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on January 7, 2005, primarily to announce updated earnings guidance for both the fiscal year 2004 and the upcoming fiscal year 2005. The key information for investors lies within the press release (Exhibit 99.1) attached to this filing, which provides forward-looking financial expectations. While the 8-K itself is brief, the supplemental guidance in the press release is crucial for assessing the company's performance trajectory and its outlook.
Key Highlights
- 1Elevance Health (then WellPoint, Inc.) issued updated earnings guidance for fiscal year 2004.
- 2The company also provided updated earnings guidance for fiscal year 2005.
- 3The information was disseminated through a press release dated January 7, 2005, filed as Exhibit 99.1.
- 4This filing signals a proactive approach to informing investors about expected financial performance.
- 5Investors should review the press release for specific details on the revised earnings per share (EPS) and revenue expectations.
- 6The filing underscores the importance of management's financial projections in investor decision-making.
Frequently Asked Questions
The primary purpose of this 8-K filing by Elevance Health (then WellPoint, Inc.) is to announce updated earnings guidance for the fiscal years 2004 and 2005 to its investors, as detailed in an accompanying press release.
The specific details of the updated earnings guidance for 2004 and 2005 are contained within the press release dated January 7, 2005, which is included as Exhibit 99.1 to this 8-K filing.
No, this 8-K filing does not include financial statements or pro forma financial information. It solely serves as an announcement of updated earnings guidance through an attached press release.
The filing was signed by David C. Colby, Executive Vice President and Chief Financial and Accounting Officer of WellPoint, Inc. (now Elevance Health, Inc.).